ad image

Company Info

Rentschler Biopharma SE

Rentschler Biopharma SE

CDMO

Overview

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) focused exclusively on clients' projects. Rentschler Biopharma offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support. The company's clients include innovative biotech companies and major pharmaceutical companies around the world. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy, and advanced technologies ensure product quality and productivity at each development and manufacturing step. 
Rentschler Biopharma SE
Contributions
20 Contributions1 / 1
Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation
AAV Quality

Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation

Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.

Rentschler Biopharma SE

PAO-11-24-CL-06Dec 02, 2024
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
PPQ

Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months

Jessica Feldman, Ph.D.; Henning Gerschewski

Rentschler Biopharma SE

PAO-10-24-CL-12Dec 02, 2024
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Expansion

Building on a Pioneering Biomanufacturing Legacy with Client Centricity

Benedikt von Braunmühl; Tom Roberts

Rentschler Biopharma SE

PAO-09-24-CL-05Sep 09, 2024
Rentschler Biopharma SE
Strategic Alliance

Rentschler Biopharma and Vetter Unveil Xpert Alliance

Rentschler Biopharma SE

PR-M03-22-14Mar 29, 2022
Investing and Expanding for High-Quality Biopharmaceuticals
Biopharmaceutical Manufacturing

Investing and Expanding for High-Quality Biopharmaceuticals

Rentschler Biopharma SE

PAO-02-22-R250-19Feb 24, 2022
Collaborating Strategically and Leveraging Innovation to Drive Success
Integrated Services

Collaborating Strategically and Leveraging Innovation to Drive Success

Federico Pollano

Rentschler Biopharma SE

PAO-10-21-CL-18Nov 22, 2021
Rentschler Biopharma SE

Vetter and Rentschler Biopharma Further Strengthen Their Strategic Alliance

Rentschler Biopharma SE

PR-M04-21-028Apr 28, 2021
Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma
Cover Story

Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma

Rentschler Biopharma SE

PAP-Q4-20-CL-028Dec 09, 2020
Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing
Industry Leader

Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing

Frank Mathias, Ph.D.

Rentschler Biopharma SE

PAP-Q4-20-CL-023Dec 09, 2020
Better Together: Collaborating to Simplify Complexities in Drug Development
Collaboration

Better Together: Collaborating to Simplify Complexities in Drug Development

Peter Soelkner; Frank Mathias, Ph.D.

Vetter Pharma International GmbH

PAP-Q3-20-CL-028Sep 29, 2020
Rentschler Biopharma SE
Collaboration

The Key to Tackling Drug Development Complexity: Collaboration

Rentschler Biopharma SE

PR-M07-20-NI-005Jul 07, 2020
Rentschler Biopharma SE
Collaboration

Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility

Rentschler Biopharma SE

PR-M05-20-NI-038May 27, 2020
A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership
CDMO Leadership

A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership

Frank Mathias, Ph.D.

Rentschler Biopharma SE

PAP-Q1-20-CL-003Mar 19, 2020
Driving Innovation to Support Strategic Client Partnerships
Innovation

Driving Innovation to Support Strategic Client Partnerships

Federico Pollano

Rentschler Biopharma SE

PAP-Q2-2019-CL-028May 24, 2019
Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position
Benefitting U.S. Clients

Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position

Federico Pollano

Rentschler Biopharma SE

PAP-Q1-2019-CL-033Mar 12, 2019
Rentschler Biopharma SE
Acquisition

Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site

Rentschler Biopharma SE

PR-M01-19-NI-021Jan 04, 2019
Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector
CDMO

Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector

Federico Pollano

Rentschler Biopharma SE

PAP-Q3-18-CL-004Oct 02, 2018
BioPharma CDMO Success Requires Technical Leadership and Problem-Solving Capabilities
Market Expansion

BioPharma CDMO Success Requires Technical Leadership and Problem-Solving Capabilities

Federico Pollano

Rentschler Biopharma SE

PAP-Q2-18-CL-019May 29, 2018
Rentschler Biopharma SE
CEO

Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer

Rentschler Biopharma SE

PR-M02-18-NI-018Feb 06, 2018
Building a One-Stop Shop CDMO for Biopharmaceuticals
CDMO

Building a One-Stop Shop CDMO for Biopharmaceuticals

Federico Pollano

Rentschler Biopharma SE

PAP-Q2-17-CL-012Jun 05, 2017
1 / 1